3861 results for «421»
3861 results
Abluminus DES+: an innovative solution going global to beat diabetes
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Luca Testa, Alexandre Abizaid and Marie-Claude Morice in order to know more about the need of a dedicated DES+ for diabetic patients and the technology behind it and the updates on ongoing and upcoming studies and trials, as well...
PCI of calcified coronaries - we will rock you! (Part 2) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to revisit strategies and devices for treatment of calcified plaque, to discuss the role of available options and to review in-depth procedural techniques for Orbital atherectomy.
This session was originally presented during EuroPCR 2021.
Leading with evidence, latest clinical outcomes update for Firesorb, Firehawk and VitaFlow
19 May 2021 – From EuroPCR 2021
Watch this session presented by Alexandra Lansky, Andreas Baumbauch, Junbo Ge and Bo Xu in order to learn about the one-year results from a pivotal RCT (FUTURE II), the four-year results from TARGET AC, and the four-year results from VitaFlow transcatheter aortic valve system in patients with severe aortic...
Contemporary adoption of invasive coronary physiology with microcatheter-based technology
19 May 2021 – From EuroPCR 2021
Watch this session presented by Emanuele Barbato, Bernard De Bruyne, Jeroen Sonck, Simone Biscaglia, Salvatore Brugaletta and Carlos Collet in order to understand the role of microcatheter-based physiology also through a critical appraisal of the available literature, to know how to correctly adopt the novel TruePhysio microcatheter, and...
A case-based approach: finding balance between bleeding and ischemic risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by David Kandzari, Mirvat Alasnag, Emmanouil Brilakis, Chorcheung Frankie Tam and Beatriz Vaquerizo in order to debate case complexity of patient characteristics and complex lesions in HBR patients, to review patient centered clinical judgment and individualised treatment plans, and to analyse current Onyx ONE...
Revascularisation for chronic coronary syndrome and multivessel disease - Part 2
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.
This session was originally presented during EuroPCR 2021.
Multivessel disease revascularisation: balancing the risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...
Challenges and opportunities in high-risk patients undergoing TAVI
19 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation
Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4
19 May 2021 – From EuroPCR 2021
Watch this session presented by Francesco Maisano, Philipp Lurz, Fabien Praz, Patrizio Lancellotti and Georg Nickenig in order to learn about patient diagnosis and selection for tricuspid transcatheter treatment with TriClip, about latest clinical data supporting TriClip therapy, and about real life experience and attest product innovation: TriClip G4.
EuroPCR 2021 Hotlines / Late-Breaking Trials in ACS: COOL AMI EU pivotal rial and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in ACS:
- COOL AMI EU pivotal trial
- Complete versus incomplete revascularization in NSTEMI patients
- Non-hyperaemic IMRangio and long-term clinical outcome in STEMI
New horizons in tricuspid therapy, the TricValve solution
19 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Haude, Christoph Naber, Mohamed Abdel-Wahab, Mohd Ghazi Azmee, Yahaya Shaiful Azmi, Katharina Kiss and Ignacio Amat Santos in order to learn about the TricValve system's approach to tricuspid regurgitation and right heart disease, to understand how this new generation of tricuspid valve system may...
Paclitaxel and sirolimus coated balloons: create evidence before claims
20 May 2021 – From EuroPCR 2021
Watch this session presented by Mohd Ali Rosli, Bruno Scheller, Raban Jeger and Sylvia Otto in order to join a controversial discussion about a sirolimus and paclitaxel coated balloon approach, to follow a dedicated discussion on existing evidence on efficacy and safety for paclitaxel and sirolimus coated balloons...
How does Paradise renal denervation fit into hypertension treatment management?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Felix Mahfoud, Philipp Lurz, Konstantinos Tsioufis and Joachim Weil in order to understand the ultrasound-based renal denervation procedure and summary of the latest clinical data, to review consensus statements and guidelines for the renal denervation therapy today, and to hear expert perspectives on how to establish...
Percutaneous mitral treatment: repair - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand patient selection for percutaneous mitral treatment, to select percutaneous valve repair or replacement and to learn tips and tricks in percutaneous valve treatment.
This session was originally presented during EuroPCR 2021.
Percutaneous mitral treatment: replacement
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand patient selection for percutaneous mitral treatment, to select percutaneous valve repair or replacement, and to learn tips and tricks in percutaneous valve treatment.
This session was originally presented during EuroPCR 2021.
Coronary access after TAVI, a growing need
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...
Shock the Rock: new intravascular lithotripsy real-world data and cases
18 May 2021 – From EuroPCR 2021
Watch this session presented by Emanuele Barbato, Holger Nef, Arif Al Nooryani, Alfonso Ielasi, Michael Haude, Margaret McEntegart and Flavio Luciano Ribichini in order to learn how to optimally adopt Intravascular Lithotripsy (IVL) for treatment of calcified lesions, to identify best practices when using IVL in different clinical settings,...
The new Evolut PRO+ system: optimal procedural outcomes in all patients
20 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...
Improving personalised vascular care using novel technologies: how can I start?
19 May 2021 – From EuroPCR 2021
Watch this session presented by Salvatore Brugaletta, Nick West, Rasha Al-Lamee, Will Davies, Angela H.E.M. Maas and William Wijns in order to learn more about personalised vascular healthcare, to understand the value of personalised vascular healthcare, and to see practical examples on how this can be implemented in your practice.
Redefining hypertension management with renal denervation
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jeffrey Popma, David Kandzari, Felix Mahfoud and Andrew Sharp in order to understand the latest data on the safety and efficacy of radiofrequency renal denervation including future studies, to learn about the long-term durability of renal denervation in a real-world patient population, and...
